Pacira BioSciences, Inc. (PCRX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Pacira BioSciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 163.97x | -8.75x | 37.17x | 110.48x | 63.44x | 17.55x |
| P/B Ratio | 1.66x | 1.12x | 1.79x | 2.27x | 3.65x | 4.12x |
| P/S Ratio | 1.59x | 1.24x | 2.31x | 2.64x | 4.92x | 5.94x |
| Profitability | ||||||
| Gross Margin | 79.4% | 75.7% | 72.6% | 70.1% | 74.1% | 72.7% |
| Operating Margin | 4.6% | -10.5% | 13.0% | 9.0% | 16.6% | 10.8% |
| Net Margin | 1.0% | -14.2% | 6.2% | 2.4% | 7.8% | 33.9% |
| EBITDA Margin | 16.9% | 4.2% | 22.9% | 21.1% | 21.0% | 14.8% |
| Liquidity | ||||||
| Current Ratio | 4.54x | 2.40x | 5.24x | 3.37x | 1.66x | 2.57x |
| Quick Ratio | 3.28x | 2.00x | 4.17x | 2.72x | 1.47x | 2.32x |
| Leverage | ||||||
| Debt/Equity | 0.66x | 0.82x | 0.67x | 0.99x | 1.55x | 0.87x |
YoY = year-over-year change. Source: FMP..